medigraphic.com
ISSN 1561-3186 (Electronic)

2015, Number 2

<< Back Next >>

Rev Acta Médica 2015; 16 (2)

Mitomycin C in the treatment or epithelial conjunctive-corneal neoplasias

Alemañy GJ, Aragonés CB, Moreno LMM

Language: Spanish
References: 34
Page:
PDF size: 155.66 Kb.


ABSTRACT

Introduction: conjunctive tumors are the most frequent of the ocular globe. They cover a wide range from benign lesions to others that may put in danger the patient’s visual function and life.
Objective: to assess the results of the treatment of mitomycin C in epithelial conjunctive-corneal neoplasia.
Method: a cross-sectional descriptive study was carried out in patients referred to the Oculoplastics consultation of "Hermanos Ameijeiras" Hospital from June 2008 and December 2012.
Results: patient at ages 50-64 years predominated (38.1%); 78.6% of the patients were white; 7.5% had a history of human papillomavirus infection; 2.5% of skin and eye cancer, and 5% of human immunodeficiency virus infection; 70% of the patients had any exposition to sunlight; in 71.4 of the le lesion was localized in the limbocorneal region; the squamous carcinoma was the most identified (42% of the patients; there was not relapses and only three complications to treatment occurred).
Conclusions: mitomycin C is useful and secure in the treatment of epithelial conjunctive-corneal neoplasia, with minimum complications.


REFERENCES

  1. Shields CL, Shields JA. Tumors of the conjunctiva and cornea. Surv Ophthalmol. 2004;9:3-24.

  2. Portero Benito A, Sanchez Mannarelli F, Carreño Salas E, Muñoz MF, Saornil MA. Spectrum of conjunctival tumors in an ocular oncology unit: review of 314 cases. Acta Ophthalmol Scand. 2008;243:667.

  3. Mauriello Jr. JA, Napolitano J, McLean I. Actinic queratosis and dysplasia of the conjunctiva:a clinicopathological study of 45 cases. Can J Ophthalmol. 1995;30:312-6.

  4. Ramos López JF, Martínez Costa Pérez R, Cisneros Lanuza Al. Tratamiento de las neoplasias conjuntivales intraepiteliales con colirio de mitomicina C al 0,02 %. Arch Soc Esp Oftalmol. 2004;79:8.

  5. García Martín E, Fernández Tirado FJ. Tendencias en el tratamiento de los carcinomas basocelulares perioculares. Arch Soc Esp Oftalmol. 2010;85:261-2.

  6. Cha SB, Shields CL, Shields JA. Squamous cell carcinoma of the conjunctiva. J Ophtalmic Nurs Technol. 2012;11:266-71.

  7. Napora C, Cohen EJ, Genvert GI, Presson AC, Arentsen JJ, Eagle RC, et al. Factors associated with conjunctival intraepithelial neoplasia: a case control study. Ophthalmic Surg. 1990;21:27-30.

  8. Tornesello ML, Duraturo ML, Waddell KM, Biryahwaho B, Downing R, Balinandi S, et al. Evaluating the role of human papilloma viruses in conjunctival neoplasia. Br J Cancer. 2009;94:446-9.

  9. Tabin G, Levin S, Snibson G, Loughnan M, Taylor H. Late recurrences and the necessity for long-term follow-up in corneal and conjunctival intraepithelial neoplasia. Opthalmology. 2007;104:485-92.

  10. American Academy of Ophthalmology. BCSC 4. Ophthalm Pathol Intraocular Tumors. 2010;43-59.

  11. Akpek ED, Kalayci D, Hasiripi H. Postoperative topical mitomycin C in conjunctival squamous cell neoplasia. Cornea. 2009;18:59-62.

  12. Cartsburg O, Kallen C, Hillenkamp J, Sundmacher R, Pomjanski N, Bocking A. Topical mitomycin C and radiation induce conjunctival DNA-polyploidy. Anal Cell Pathol. 2011;23:65-74.

  13. Aoki S, Kubo E, Nakamura S, Tsuzuki A, Tsuzuki S, Takahashi Y, et al. Possible prognostic markers in conjunctival dysplasia and squamous cell carcinoma. Jap J Ophthalmol. 2008;42:256-61.

  14. Sterker Y, Lommatzsch P. Results of treatment in malignant epithelial conjunctival tumors. Ophthalmology. 2007;90:62-5.

  15. Cervantes G, Rodriguez Jr. AA, Leal AG. Squamous cell carcinoma of the conjunctiva: clinicopathological features in 287 cases. Can J Ophthalmol. 2012;37:14-9.

  16. Midena E, Angeli CD, Valenti M, Belvis V de, Boccato F. Treatment of conjunctival squamous cell carcinoma with topical 5- fluotroutracil. Br J Ophthalmol. 2009;84:268-312.

  17. Lee GA, Hirst LW. Retrospective study of ocular surface squamous neoplasia. Aust NZJ Ophthalmol. 2010;25:269-76.

  18. Espana EM, Prabhasawat P, Grueterich M, Solomon A, Tseng SCG. Amniotic membrane transplantation for reconstruction after excision of large ocular surface neoplasias. Br J Ophthalmol. 2008;86:640-5.

  19. Copeland RA. Limbal autograft for reconstruction after conjunctival squamous cell carcinoma. Am J Ophthalmol. 2010;4:412-5.

  20. Newton R, Ziegler J, Ateenyi-Agaba C, Bousarghin L, Casabonne D, Beral V, et al. The epidemiology of conjunctival squamous cell carcinoma in Uganda. Br J Cancer. 2012;87:301-8.

  21. Frucht Pery J, Sugar J, Baum J, Sutphin JE, Pe'er J, Savir H, et al. Mitomycin C treatment for conjunctival-corneal intraepithelial neoplasia: a multicenter experience. Ophthalmology. 2007;104:2085-93.

  22. Mahomed A, Chetty R. Human immunodeficiency virus infection, Bcl-2, p53 protein, and Ki-67 analysis in ocular surface squamous neoplasia. Arch Ophthalmol. 2012;120:554-8.

  23. Nakamura Y, Mashima Y, Kameyama K, Mukai M, Oguchi Y. Detection of human papillomavirus infection in squamous tumours of the conjunctiva and lacrimal sac by immunohistochemistry, in situ hybridisation and polymerase chain reaction. Br J Ophthalmol.2010; 81:308-13.

  24. Tabin G, Levin S, Snibson G, Loughnan M, Taylor H. Late recurrences and the necessity for long-term follow-up in corneal and conjunctival neoplasia. Ophthalmology. 2010;104:485-92.

  25. Olasode BJ, Bankole OO, Adeoye AO. Invasive squamous cell carcinoma of the limbus: case report. East Afr Med J. 2009;73:627-8.

  26. Waddell KM, Lewallen S, Lucas SB, Atenyi-Agaba C, Herrington CS, Liomba G. Carcinoma of the conjunctiva and HIV infection in Uganda and Malawi. Br J Ophthalmol. 2010;80:503-8.

  27. Castano AP, DemidovaTN, Hamblin MR. Mechanisms in photodynamic therapy: Part three-photosensitizer pharmacokinetics, biodistribution, tumor localization and modes of tumor destruction. Photodiagnosis Photodyn Ther. 2005;2:91-106.

  28. Margo CE, Harman LE, Mulla ZD. The reliability of clinical methods in ophthalmology. Surv Ophthalmol. 2012;47:375-86.

  29. McKelvie PA, Daniell M. Impression cytology following mitomycin C therapy for ocular surface squamous neoplasia. Br J Ophthalmol. 2011;85:1115-9.

  30. Lake DF, Briggs AD, Akporiaye ET. Immunopharmacology. Basic and clinical pharmacology. 9th.ed. Boston: McGraw Hill; 2010.p. 931-57.

  31. McKelvie PA, Daniell M, McNab A, Loughnan M, Santamaria JD. Squamous cell carcinoma of the conjunctiva: a series of 26 cases. Br J Ophthalmol. 2012;86:168-73.

  32. Karp CL, Moore JK, Rosa Jr. RH. Treatment of conjunctival and corneal intraepithelial neoplasia with topical interferon alpha-2b. Ophthalmology. 2011;108:1093-8.

  33. Herman MD, Feldman KA, Farahmand SM, Margolis TP. Treatment of conjunctival squamous cell carcinoma with topical cidofovir. Am J Ophthalmol. 2012;134:432-3.

  34. Sudesh S, Rapuano CJ, Cohen EJ, Eagle Jr. RC, Laibson PR. Surgical management of ocular surface squamous neoplasms: the experience from a cornea center. Cornea. 2010;19:278-83.




2020     |     www.medigraphic.com